Sun Pharma is an international, integrated, speciality pharmaceutical company with manufacturing units for API and FDF in India, USA, Latin America & Europe. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. It is backed by 2 state of the art R&D Centers with a team of 600+ scientists for projects in Chemical Synthesis, Clinical Research & formulation development Sun is a leader in niche therapy areas & has strong skills in product development,process chemistry, and manufacturing of complex API, & dosage forms. 

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products

Lacoset 100

Sun Pharmaceutical Ind. Ltd.

Request Info

Lacoset 150

Sun Pharmaceutical Ind. Ltd.

Request Info

Lacoset 200

Sun Pharmaceutical Ind. Ltd.

Request Info

Lacoset 50

Sun Pharmaceutical Ind. Ltd.

Request Info